Monocyte cytokine production

Monocyte cytokine production is a complex biological process involving the synthesis and secretion of various pro-inflammatory and anti-inflammatory signaling proteins, such as Tumor Necrosis Factor-alpha (TNF-α), Interleukin-1 beta (IL-1β), and Interleukin-6 (IL-6), by monocytes in response to stimuli (Source: StatPearls, Monocytes, 2023). This process is a cornerstone of the innate immune response, acting as a primary driver of inflammation and a bridge to adaptive immunity (Source: NIH, National Institute of Allergy and Infectious Diseases). The regulation of this process involves a network of transcription factors and kinases, such as NF-kappaB and JAKs, that integrate external signals to mount an appropriate immune response (Source: Frontiers in Immunology, 2021). In pathological conditions like rheumatoid arthritis, sepsis, and cytokine release syndrome, monocytes become hyper-responsive, leading to a cytokine storm or chronic inflammation that causes significant tissue damage (Source: PubMed, PMID: 31431615). While not a single molecular target, the modulation of monocyte cytokine production is a major therapeutic strategy; drugs such as corticosteroids and JAK inhibitors are designed to interrupt the intracellular signaling pathways that govern this production (Source: Nature Reviews Rheumatology, 2019). Consequently, monitoring these cytokine levels in monocyte-based assays is a critical pharmacodynamic tool for assessing the efficacy and potency of immunomodulatory therapies in clinical and preclinical settings (Source: Journal of Immunological Methods, 2020).

Other names

Monocyte activationMonocytic cytokine releaseCytokine production by monocytesMonocyte-derived cytokine synthesis

Inhibition of pro-inflammatory signaling pathways, such as the JAK-STAT or NF-κB pathways, and activation of the glucocorticoid receptor to suppress the transcription of cytokine genes (Source: Pharmacology & Therapeutics, 2021; Nature Reviews Drug Discovery, 2017).